Peter Buhl Jensen
Vorstandsvorsitzender bei CHOSA ONCOLOGY AB
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ulla Hald Buhl | F | 60 |
Allarity Therapeutics Europe ApS
 Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark.
Buhl Krone Holding ApS
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 19 Jahre |
| Steen Meier Knudsen | M | 63 |
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark.
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
Medical Prognosis Institute, Inc.
| 20 Jahre |
| Thomas Jensen | M | 46 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 20 Jahre |
| Claus Frisenberg Pedersen | M | 52 |
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | 6 Jahre |
| Marcus Kåre Torleif Larsson | M | 51 | 9 Jahre | |
| Jørgen Vilhelm Bardenfleth | M | 69 |
Cobis A/S
 Cobis A/S Miscellaneous Commercial ServicesCommercial Services Cobis A/S provides business support services.
Symbion Fonden
Symbion A/S
 Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | 15 Jahre |
| Duncan Moore | M | 65 |
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark.
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 9 Jahre |
| Gunnar Magnus Modee Persson | M | 64 |
Medical Prognosis Institute, Inc.
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 7 Jahre |
| Carani Sanjeevi | M | 66 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | 3 Jahre |
| Ingrid Atteryd Heiman | F | 66 | 3 Jahre | |
| Kristian Helin | M | - |
University of Copenhagen
| - |
| Niels Kærgård | M | 81 |
University of Copenhagen
| 16 Jahre |
| Alexandra Ellervik | F | - | - | |
| Christopher Bravery | M | 57 | 3 Jahre | |
| Jesper Zeuthen | M | - |
University of Copenhagen
| - |
| Sven Fredrik Tiberg | M | 61 | 3 Jahre | |
| Peter Gæmelke | M | 69 |
University of Copenhagen
| - |
| Magnus Fontes | M | 61 |
University of Copenhagen
| - |
| Jacob Rosenberg | M | 59 |
University of Copenhagen
| 21 Jahre |
| Karen Laigaard | F | 58 |
University of Copenhagen
| - |
| Gunhild Waldemar | M | 67 |
University of Copenhagen
| - |
| Lars Henrik Fugger | M | 64 |
University of Copenhagen
| 15 Jahre |
| David Woldbye | M | 61 |
University of Copenhagen
| - |
| Carsten Gomard | M | 58 |
University of Copenhagen
| - |
| Povl Krogsgaard-Larsen | M | 83 |
University of Copenhagen
| - |
| Lars Olof Hedbys | M | 67 | 1 Jahre | |
| Jan Stenvang | M | - |
University of Copenhagen
| 11 Jahre |
| Jørgen Honoré | M | - |
Symbion A/S
Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | - |
| Benedicte Jorgensen | F | - |
Symbion A/S
Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | - |
| Kristine Færch | F | 48 |
University of Copenhagen
| - |
| Steven Goldman | M | 66 |
University of Copenhagen
| 10 Jahre |
| Jan Talts | M | 59 | 7 Jahre | |
| Matilda Hugerth | F | 49 | - | |
| Thomas Bjarnsholt | M | - |
University of Copenhagen
| - |
| Jan Hesthaven | M | - |
University of Copenhagen
| - |
| Mikkel Bogh | M | - |
University of Copenhagen
| - |
| Boel Flodgren | M | 82 |
University of Copenhagen
| - |
| Ole Thastrup | M | 71 |
University of Copenhagen
| - |
| Brian List | M | - |
Symbion A/S
Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | - |
| Thue Walter Schwartz | M | - |
University of Copenhagen
| - |
| Marie Foegh | M | 82 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 6 Jahre |
| Thomas Jonassen | M | - |
University of Copenhagen
| - |
| Lars Åke Alvar Lidgren | M | 81 |
University of Copenhagen
| - |
| Steen Meier Rønborg | M | 70 |
University of Copenhagen
| - |
| Per Holten-Andersen | M | - |
Symbion A/S
Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | - |
| Per Stahl Skov | M | 78 |
University of Copenhagen
| 43 Jahre |
| Ellen Holm Nielsen | F | - |
University of Copenhagen
| - |
| Peter Birk Rasmussen | M | 59 |
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | 9 Jahre |
| Nils Aage Brünner | M | 72 |
University of Copenhagen
| 22 Jahre |
| Neil Goldsmith | M | 61 | 1 Jahre | |
| Niels Borregaard | M | 73 |
University of Copenhagen
| 26 Jahre |
| Mai-Britt Zocca | M | 56 |
Cobis A/S
Cobis A/S Miscellaneous Commercial ServicesCommercial Services Cobis A/S provides business support services. | - |
| Lars Søren Rasmussen | M | 65 |
University of Copenhagen
| - |
| Karsten Kristiansen | M | - |
University of Copenhagen
| - |
| Lykke Friis | M | 54 |
University of Copenhagen
| - |
| Agnete Raaschou-Nielsen | M | 66 |
University of Copenhagen
| - |
| Jens Borum | M | 70 |
University of Copenhagen
| - |
| Søren Hougaard | M | 74 |
Symbion A/S
Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | - |
| Jakob Bo Thomasen | M | 62 |
University of Copenhagen
| - |
| Hans Siggaard Jensen | M | - |
University of Copenhagen
| - |
| Morten Bangsgaard | M | 60 |
Symbion A/S
Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | - |
| Peter Boman Samuelsen | M | - |
University of Copenhagen
| - |
| Gerton Jönsson | M | 53 | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Anders Fink Vadsholt | M | 55 | - | |
| Anders Månsson | M | 57 | 5 Jahre | |
| Bo Jesper Hansen | M | 66 | 5 Jahre | |
| Anker Gunvald Lundemose | M | 63 | - | |
| Annie Rasmussen | F | 67 | 8 Jahre | |
| Steve Carchedi | M | 62 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | - |
| Lars Stigsson | M | 71 | 2 Jahre | |
| Maxwell Sehested | M | - | - | |
| Ingelise Saunders | F | 75 | - | |
| Jeffrey H. Buchalter | M | 67 | - | |
| Johny Humaloja | M | 58 | 2 Jahre | |
| Henri Lichenstein | M | - | - | |
| Per Anders Göte Samuelsson | M | 63 | - | |
| Helle Størum | F | 57 | 3 Jahre | |
| Jan C. Fagerberg | M | 62 | 3 Jahre | |
| Niels Johansen | M | 64 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | - |
| Leif Schimmel Hamø | M | - | 7 Jahre | |
| Ole Wiborg | M | - | 1 Jahre | |
| Niels Laursen | M | 68 | 5 Jahre | |
| Elisabeth V. Carstensen | M | 55 | - | |
| Nikolaj Buhl Jensen | M | 48 |
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | - |
| Anders Gersel Pedersen | M | 73 | - | |
| Kåre Engkilde | M | 47 | 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Dänemark | 71 | 82,56% |
| Schweden | 17 | 19,77% |
| Vereinigte Staaten | 2 | 2,33% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Peter Buhl Jensen
- Persönliches Netzwerk
